Vasculitis

Apremilast Approved for Oral Ulcers Associated With Behçet Disease

Publish Date July 26, 2019

The FDA has approved Otezla (apremilast; Celgene) for the treatment of adult patients with oral ulcers associated with Behçet’s disease.

Novel Risk Factors for Thromboembolism in ANCA-Associated Vasculitis

Publish Date July 8, 2019

Researchers conducted a study to examine the frequency of VTEs in ANCA-associated vasculitis, and to identify its novel risk factors.

Oral Glucocorticoid-Related Infection Incidence in Giant Cell Arteritis

Publish Date June 26, 2019

The incidence of infection increases with glucocorticoid dose for patients with polymyalgia rheumatica or giant cell arteritis.

Priority Review Granted to Rituximab for Pediatric Microscopic Polyangiitis

Publish Date June 13, 2019

The FDA has accepted for Priority Review the supplemental BLA for Rituxan for use in combination with glucocorticoids for the treatment of granulomatosis with polyangiitis and microscopic polyangiitis in children ≥2 years old.

Orbital Mass Presentation and Management Examined in ANCA-Associated Vasculitides

Publish Date April 10, 2019

Researchers described the presentation, therapeutic management, and outcomes of ANCA-associated vasculitides-related orbital mass.

Patient-Reported Outcome Measurement Information System Validated in Systemic Vasculitis

Publish Date March 27, 2019

Researchers assessed the feasibility and construct validity of using PROMIS instruments in systemic vasculitis.

Effects of Clinicopathologic Classification in ANCA-Associated Vasculitis

Publish Date March 15, 2019

Researchers assessed the effect of AAV reclassification based on clinicopathologic criteria and ANCA specificity.

Belimumab, Azathioprine Did Not Lower Risk for Relapse in ANCA-Associated Vasculitis

Publish Date February 13, 2019

Belimumab in combination with glucocorticoids and azathioprine did not lower the risk for relapse in patients with antineutrophil cytoplasm antibody-associated vasculitis.

Mycophenolate Mofetil Noninferior to Cyclophosphamide in ANCA-Associated Vasculitis

Publish Date February 1, 2019

Mycophenolate mofetil was noninferior to cyclophosphamide for remission induction, but resulted in higher rates of relapse.

Survival Predictors Identified in Patients With Biopsy-Proven Giant Cell Arteritis

Publish Date January 8, 2019

Researchers evaluated the influence of disease-related findings and treatment outcomes on survival in a population-based cohort of patients with giant cell arteritis.